Shenzhen Kaifa Technology
920029
Shanghai Yongli Belting
300230
Guomai Culture & Media
301052
4
WuHan Hvsen Biotechnology
300871
5
CHANGFU CO.,LTD
871396
US Stock MarketDetailed Quotes
APGE Apogee Therapeutics
- 39.720
- +0.470+1.20%
Close Mar 28 16:00 ET
- 39.720
- 0.0000.00%
Post 16:05 ET
2.36BMarket Cap-12.04P/E (TTM)
39.930High38.250Low415.25KVolume39.270Open39.250Pre Close16.29MTurnover1.03%Turnover RatioLossP/E (Static)59.50MShares68.21052wk High3.30P/B1.61BFloat Cap29.10052wk Low--Dividend TTM40.45MShs Float72.290Historical High--Div YieldTTM4.28%Amplitude14.190Historical Low39.221Avg Price1Lot Size
Apogee Therapeutics Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -128.96%-171.17M | -127.58%-67.71M | -113.90%-42.52M | -101.10%-29.3M | -199.67%-31.64M | -355.11%-74.76M | -223.80%-29.75M | -19.88M | -14.57M | -10.56M |
| Net income from continuing operations | -116.88%-182.15M | -111.81%-67.22M | -135.21%-49.02M | -79.06%-33.82M | -156.24%-32.09M | -111.10%-83.99M | -126.57%-31.74M | ---20.84M | ---18.89M | ---12.53M |
| Depreciation and amortization | --189K | --76K | --48K | --36K | --29K | --0 | --0 | --0 | --0 | --0 |
| Other non cash items | 1,847.13%1.69M | --761K | --387K | --280K | --266K | -99.24%87K | ---- | ---- | ---- | ---- |
| Change In working capital | -132.79%-2M | -336.16%-5.96M | 1,290.10%3.73M | -51.84%1.54M | -289.19%-1.31M | -37.80%6.11M | 19.36%2.52M | ---313K | --3.2M | --694K |
| -Change in prepaid assets | -118.31%-6.08M | -196.60%-596K | -95.34%-2.81M | 36.82%-1.21M | -3,222.73%-1.46M | -1,587.88%-2.79M | 473.94%617K | ---1.44M | ---1.92M | ---44K |
| -Change in payables and accrued expense | -43.67%5.22M | -322.04%-5.07M | 505.24%6.81M | -40.14%3.07M | -44.17%412K | -7.14%9.27M | 0.18%2.28M | --1.13M | --5.12M | --738K |
| -Change in other current assets | 9.35%-97K | 114.95%16K | ---46K | ---- | ---- | ---107K | ---107K | --0 | ---- | ---- |
| -Change in other current liabilities | -287.04%-1.05M | -14.44%-309K | ---229K | ---244K | ---263K | ---270K | ---270K | --0 | --0 | --0 |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -128.96%-171.17M | -127.58%-67.71M | -113.90%-42.52M | -101.10%-29.3M | -199.67%-31.64M | -355.11%-74.76M | -223.80%-29.75M | ---19.88M | ---14.57M | ---10.56M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -9.69%-300.46M | 216.82%46.37M | 37.50%-146.38M | -148.71M | -51.74M | -273.91M | -39.69M | -234.22M | 0 | 0 |
| Net PPE purchase and sale | -589.82%-1.15M | 100.60%1K | ---751K | ---51K | ---351K | ---167K | ---167K | --0 | --0 | --0 |
| Net investment purchase and sale | -9.34%-299.31M | 217.31%46.37M | 37.82%-145.63M | ---148.66M | ---51.39M | ---273.74M | ---39.53M | ---234.22M | --0 | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -9.69%-300.46M | 216.82%46.37M | 37.50%-146.38M | ---148.71M | ---51.74M | ---273.91M | ---39.69M | ---234.22M | --0 | --0 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 56.98%495.11M | 20,924.41%44.36M | -99.88%383K | 91.15%-150K | 450.52M | 87.38%315.39M | -100.13%-213K | 317.3M | -1.69M | 0 |
| Net common stock issuance | 56.47%493.48M | 20,535.68%43.53M | --0 | ---541K | --450.5M | --315.39M | 97.83%-213K | --315.6M | --0 | --0 |
| Proceeds from stock option exercised by employees | --1.63M | --828K | --383K | --391K | --24K | --0 | --0 | --0 | --0 | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 56.98%495.11M | 20,924.41%44.36M | -99.88%383K | 91.15%-150K | --450.52M | 87.38%315.39M | -100.13%-213K | --317.3M | ---1.69M | --0 |
| Net cash flow | ||||||||||
| Beginning cash position | -21.91%118.61M | -36.75%119.07M | 145.94%307.59M | 243.69%485.75M | -21.91%118.61M | --151.89M | 7,188.77%188.27M | --125.07M | --141.33M | --151.89M |
| Current changes in cash | 170.53%23.47M | 133.03%23.01M | -398.29%-188.52M | -995.41%-178.16M | 3,577.70%367.14M | -121.91%-33.28M | -146.65%-69.66M | --63.2M | ---16.26M | ---10.56M |
| End cash Position | 19.79%142.08M | 19.79%142.08M | -36.75%119.07M | 145.94%307.59M | 243.69%485.75M | -21.91%118.61M | -21.91%118.61M | --188.27M | --125.07M | --141.33M |
| Free cash flow | -129.99%-172.33M | -126.31%-67.71M | -117.68%-43.28M | -101.45%-29.35M | -202.99%-31.99M | -356.13%-74.93M | -225.62%-29.92M | ---19.88M | ---14.57M | ---10.56M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Market Insights
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call